Neumifil(Pneumagen)

N/A

Report date: 2024/05/24 15:10:52
NME

Base Information

Drug NameNeumifil(Pneumagen)
Drug Alias NameHEX17HEX-17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpithelial cells stimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respirovirus InfectionsRespiratory Syncytial Virus Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPneumagen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPneumagen Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respirovirus InfectionsRespiratory Syncytial Virus Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A